PTSD After Stroke: Why 1 in 6 Survivors Develop It and What Neuroplasticity Offers
- The Neuroplasticity Alliance
- May 13
- 11 min read
Updated: May 13
You survived the stroke. The clot was treated, or the bleed controlled. The acute crisis passed. And then, weeks or months later, something else arrived — something nobody warned you about.
The nightmares. The hypervigilance. The intrusive images of the moment it happened. The fear that won't quiet down even when the doctors have declared you medically stable. The way your heart pounds every time you feel something unfamiliar in your body.
For a significant proportion of stroke survivors, what follows the stroke is not just physical rehabilitation. It is something that meets the full clinical criteria for post-traumatic stress disorder.
"1 in 6 stroke survivors develops clinically significant PTSD symptoms within the first year (Edmondson & Sumner, 2013; systematic review of 4,320 patients). "
This figure — drawn from a systematic review of 30 studies involving 4,320 patients — is almost certainly an undercount. Many stroke survivors are never screened for PTSD. Many attribute their symptoms to anxiety about a second stroke, or to the general stress of recovery, without recognizing the specific neurological and psychological pattern underneath.
This article is about that pattern: what PTSD after stroke actually is, why it develops, what it does to the recovering brain, and what the emerging neuroscience — including the role of neuroplasticity-informed interventions — offers for people navigating both conditions at once.
ARTICLE SUMMARY Every year, thousands of stroke survivors complete their acute rehabilitation, return home, and find themselves struggling in ways nobody prepared them for. The nightmares. The hypervigilance. The fear that something is still wrong even when the medical team says they are stable. What most of them are never told is that what they are experiencing has a name, a neurological explanation, and evidence-based treatment options. Up to 1 in 6 stroke survivors develops post-traumatic stress disorder within the first year following their stroke. Not as a psychological reaction to a difficult experience — but as a neurological consequence of a traumatic brain event that disrupts the same circuits responsible for threat detection, emotional regulation, and memory. In this article we explain what post-stroke PTSD actually is at the neurological level, why it directly slows the neuroplastic recovery the brain is working to achieve, and what the emerging science — including a 2025 clinical trial that produced complete PTSD remission in all participants — offers for survivors and caregivers who were never given this information in the appointment. What you will find here:
If you or someone you love is navigating stroke recovery and the emotional piece has been treated as secondary — this article is for you. |
Why a Stroke Can Cause PTSD
Post-traumatic stress disorder has historically been associated with external traumatic events: combat exposure, assault, accidents, natural disasters. Stroke does not fit neatly into that category because the trauma originates inside the body. Yet the neurological and psychological conditions it creates meet every clinical criterion for a traumatic event.
A stroke is, by definition, a sudden, life-threatening event accompanied by a profound sense of loss of bodily control. Many survivors describe the moment of onset as the most terrifying experience of their lives — an event with no warning, no preparation, and no ability to escape. The brain, which is simultaneously the organ experiencing the stroke and the organ processing the experience of the stroke, is left with both the neurological damage and the neurological record of the trauma.
Robinson and Jorge (2016), in their landmark review in the American Journal of Psychiatry, established that the neurobiological consequences of stroke — including disrupted connectivity in the prefrontal cortex, limbic system, and basal ganglia — create the physiological conditions in which PTSD symptoms are likely to emerge. This is not simply a psychological reaction to a frightening event. It is a neurological injury that alters the very circuits responsible for processing threat, fear, and safety.
The Neuroscience: Three Brain Regions, Two Injuries
To understand PTSD after stroke, it helps to understand what both conditions do to the brain — and why they so often compound each other.
Stroke damages brain tissue through interrupted blood flow (Ischemic stroke) or exposure to blood (hemorrhagic stroke). Depending on the location and extent of the damage, this produces a range of physical, cognitive, and emotional deficits. PTSD, as established in research by Kredlow et al. (2022) at Harvard University and McLean Hospital, involves measurable dysfunction in three specific brain regions:
THE THREE NEUROLOGICAL CHANGES IN PTSD |
1. THE AMYGDALA — becomes hyperactive, firing threat responses to stimuli that are not objectively dangerous. In someone who has had a stroke, any unfamiliar bodily sensation can trigger the amygdala's alarm system, even when there is no new medical emergency. |
2. THE PREFRONTAL CORTEX — loses regulatory influence over the amygdala. The prefrontal cortex is the brain region responsible for rational evaluation, context, and emotional regulation. When it is weakened — by PTSD, by the stroke itself, or both — the threat response runs without its governor. |
3. THE HIPPOCAMPUS — shows reduced volume and impaired function. The hippocampus helps the brain distinguish between past and present danger. When it is compromised, the brain struggles to recognize that the threatening event is over. For stroke survivors, this means the body may remain in a state of acute threat response long after the medical crisis has resolved. |
The critical insight here is that stroke and PTSD are not two separate conditions competing for the clinician's attention. They are overlapping neurological states affecting the same circuits — and when they co-occur, each makes the other harder to recover from.
Kumar et al. (2025), in a comprehensive review published in ACS Chemical Neuroscience, established that the neurochemical dysregulation underlying PTSD — involving the hypothalamic-pituitary-adrenal (HPA) axis, monoamines, glutamate, and GABA — creates a neurobiological environment that directly impairs the brain's capacity for the adaptive plasticity that stroke rehabilitation depends on.
How PTSD Slows Stroke Recovery
The relationship between PTSD and stroke rehabilitation outcomes is not just psychological. It is neurochemical.
When the HPA axis is chronically activated — which is precisely what occurs in PTSD — the brain is flooded with sustained cortisol. McEwen's foundational research established that chronic cortisol elevation produces measurable hippocampal atrophy: the very structure already compromised by both the stroke and the PTSD is subjected to ongoing neurochemical damage.
Sustained cortisol elevation also suppresses the production of brain-derived neurotrophic factor — BDNF — the protein most critical to the neuroplastic processes that stroke rehabilitation attempts to harness. BDNF supports the growth of new neurons, the survival of existing ones, and the formation of the new synaptic connections that functional recovery depends on. PTSD, through the HPA axis, systematically degrades the neuroplastic environment that rehabilitation is trying to build.
In concrete terms: an unaddressed PTSD diagnosis in a stroke survivor is not simply an emotional burden running alongside the physical recovery. It is an active neurobiological impediment to the neuroplastic processes on which that recovery depends. Robinson and Jorge (2016) found that stroke survivors with comorbid depression and anxiety — conditions that frequently co-occur with PTSD and share its neurobiological substrate — showed significantly worse functional recovery outcomes at 12 months compared to those whose mental health was integrated into the rehabilitation plan.
"17.5% Weighted median prevalence of PTSD across 30 stroke studies (4,320 patients) Rising to 37% in subarachnoid hemorrhage survivors (Systematic review, ScienceDirect, 2024) ."
Recognizing Post-Stroke PTSD: What to Look For
Part of the reason post-stroke PTSD is underdiagnosed is that its symptoms are easily attributed to other aspects of stroke recovery. The hypervigilance reads as understandable anxiety about a second stroke. The intrusive thoughts read as rumination. The emotional numbing reads as depression. The sleep disruption reads as insomnia.
The clinical distinction matters because the interventions differ. Screening for PTSD-specific symptoms — re-experiencing, avoidance, hyperarousal, and negative changes in cognition and mood persisting for more than one month — can identify survivors who need more targeted support than general anxiety management provides.
COMMON SYMPTOMS OF POST-STROKE PTSD — WHAT TO ASK ABOUT |
• Intrusive re-experiencing of the stroke event — flashbacks, nightmares, or unwanted memories |
• Avoidance — avoiding reminders of the stroke, including medical settings, certain activities, or conversations about what happened |
• Hypervigilance — heightened alertness to bodily sensations; frequent fear that another stroke is occurring |
• Emotional numbing or detachment — feeling disconnected from life, from relationships, or from the future |
• Sleep disturbances — difficulty falling or staying asleep; nightmares related to the stroke event |
• Negative changes in beliefs about self or recovery — persistent hopelessness, self-blame, or conviction that full recovery is impossible |
NOTE: If these symptoms have persisted for more than one month following the stroke and are affecting daily functioning, ask your neurologist or primary care provider for a PTSD screening. The PCL-5 (PTSD Checklist for DSM-5) is a validated, widely used screening tool. |
What Neuroplasticity Offers: The Path Toward Recovery
The same neuroplasticity that makes PTSD after stroke so damaging — the brain's capacity to reorganize its structure and function in response to experience — is also the mechanism through which recovery is possible.
The amygdala that has become hyperreactive can be recalibrated. The prefrontal cortex that has lost regulatory influence can regain it. The hippocampus that has lost volume can, under the right conditions, restore it. These are not theoretical possibilities. They are documented in peer-reviewed research across multiple intervention types.
Trauma-Informed Therapy
Prolonged exposure therapy and cognitive processing therapy — the two most evidence-supported PTSD treatments — work precisely because they leverage neuroplasticity. Repeated, structured engagement with the traumatic memory in a safe context drives the prefrontal cortex to form new regulatory pathways over the amygdala's threat response. The brain does not forget the stroke. It learns that the threat is no longer active.
For stroke survivors, the important consideration is that trauma-informed therapy needs to be adapted to account for potential cognitive and language deficits. Aphasia, memory impairment, or processing difficulties do not preclude PTSD treatment — they require modification of the approach. This adaptation is the responsibility of a trained clinician, and it is achievable.
Vagus Nerve Stimulation: A Neuroplasticity Accelerant
The most significant recent development in neuroplasticity-informed PTSD treatment involves vagus nerve stimulation — a technology with an established track record in stroke motor rehabilitation that has now shown unprecedented results in treatment-resistant PTSD.
In 2025, Powers et al. published the results of a clinical trial in Brain Stimulation in which nine patients with treatment-resistant PTSD — individuals who had not responded to existing therapies — underwent prolonged exposure therapy paired with VNS. A miniaturized implantable device delivered brief electrical pulses to the vagus nerve during therapy sessions, triggering the release of neuromodulators including acetylcholine and norepinephrine throughout the cortex.
After completing the treatment, all nine participants no longer met the diagnostic criteria for PTSD. At six-month follow-up, all remained symptom-free.
The mechanism works by triggering neuroplasticity. VNS does not suppress PTSD symptoms — it enhances the brain's capacity to form new neural connections during therapy, making the rewiring process more efficient and more durable. The same mechanism that underlies the Vivistim Paired VNS System's FDA-approved efficacy in stroke motor rehabilitation — where 65-82% of patients showed functional improvement in clinical trials — is being applied to the fear circuits disrupted by PTSD.
"VNS does not suppress PTSD symptoms. It enhances the brain's capacity to form new neural connections during therapy — making the rewiring process more efficient and more durable."
Aerobic Exercise
Aerobic exercise is one of the most evidence-supported neuroplasticity interventions available to both stroke survivors and people with PTSD — and for the same neurobiological reason: it increases BDNF production. The protein that stroke rehabilitation needs to drive cortical reorganization is the same protein that PTSD suppresses through chronic HPA axis activation. Regular aerobic exercise is, in this context, both a rehabilitation tool and a direct counter to one of PTSD's most damaging neurochemical effects.
Erickson et al. (2011) demonstrated that aerobic exercise increases hippocampal volume by approximately 2% in older adults, directly reversing stress-related atrophy. For stroke survivors with comorbid PTSD, this finding has particular significance: the hippocampus is under attack from two directions, and aerobic exercise addresses both simultaneously.
Nervous System Regulation
Vagal activation through slow, diaphragmatic breathing — specifically an exhale longer than the inhale — signals the parasympathetic nervous system to downregulate the HPA axis. With repeated practice, this becomes a learned neurological pattern: the prefrontal cortex strengthens its regulatory influence over the amygdala, and the chronic hyperactivation of PTSD begins to quiet.
This is not alternative medicine. The neurobiological mechanism is well-documented in Porges's polyvagal theory and supported by Hölzel et al.'s (2011) finding that 8 weeks of mindfulness practice produced measurable reductions in amygdala grey matter density — the physical architecture of stress reactivity.
What to Do If This Resonates
IF YOU OR SOMEONE YOU LOVE IS A STROKE SURVIVOR EXPERIENCING THESE SYMPTOMS |
1. NAME IT. Post-stroke PTSD is a recognized clinical condition. It is not weakness, it is not character failure, and it is not simply the anxiety of someone who has been through something hard. It is a neurological state with a name, a mechanism, and evidence-based interventions. |
2. ASK TO BE SCREENED. Ask your neurologist, rehabilitation physician, or primary care provider specifically about PTSD screening. The PCL-5 takes five minutes to complete. If PTSD is identified, ask for a referral to a trauma-informed therapist with experience in neurological populations. |
3. BRING THIS ARTICLE. If your care team is unfamiliar with post-stroke PTSD or its neurological basis, the research cited below provides a starting point for a more informed conversation. |
4. CONSIDER THE FULL PICTURE. Effective stroke recovery increasingly means integrating the neurological and the psychological — not as two separate tracks, but as the same process. Neuroplasticity does not distinguish between physical rehabilitation and emotional recovery. The conditions that support one support both. |
The Bottom Line
Approximately 1 in 6 stroke survivors develops PTSD — a neurological condition, not just a psychological reaction, that involves measurable structural changes in the amygdala, prefrontal cortex, and hippocampus. When it co-occurs with stroke, it creates a neurochemical environment that actively slows the neuroplastic recovery the brain is trying to achieve.
It is underdiagnosed, under-screened, and undertreated in standard stroke rehabilitation settings. That gap is not a reflection of its significance — it is a reflection of how fragmented neurological and psychiatric care still tend to be.
The emerging science — including the 2025 VNS trial results that produced complete PTSD remission in all participants — suggests that this is a condition the brain can recover from. The neuroplasticity that trauma disrupted is the same neuroplasticity through which recovery is possible.
NPA exists to translate that research for the people who need it. If this article helped you understand something about your own experience, or gave you language to bring to a clinical conversation, that is exactly what it was written for.
References
Cotman, C. W., & Berchtold, N. C. (2002). Exercise: a behavioral intervention to enhance brain health and plasticity. Trends in Neurosciences, 25(6), 295–301. https://doi.org/10.1016/S0166-2236(02)02143-4
Edmondson, D., & Sumner, J. A. (2013). Prevalence of PTSD in survivors of stroke and transient ischemic attack: a meta-analytic review. PLOS ONE, 8(6), e66435. https://doi.org/10.1371/journal.pone.0066435
Erickson, K. I., Voss, M. W., Prakash, R. S., Basak, C., Szabo, A., Chaddock, L., … Kramer, A. F. (2011). Exercise training increases size of hippocampus and improves memory. Proceedings of the National Academy of Sciences, 108(7), 3017–3022. https://doi.org/10.1073/pnas.1015950108
Hölzel, B. K., Carmody, J., Vangel, M., Congleton, C., Yerramsetti, S. M., Gard, T., & Lazar, S. W. (2011). Mindfulness practice leads to increases in regional brain gray matter density. Psychiatry Research: Neuroimaging, 191(1), 36–43. https://doi.org/10.1016/j.pscychresns.2010.08.006
Kredlow, M. A., Fenster, R. J., Laurent, E. S., Ressler, K. J., & Phelps, E. A. (2022). Prefrontal cortex, amygdala, and threat processing: implications for PTSD. Neuropsychopharmacology, 47(1), 247–259. https://doi.org/10.1038/s41386-021-01155-7
Kumar, S., Dhanik, K., Gaur, P., Dwivedi, S., & Nair, R. (2025). Neurochemical, neurocircuitry, and psychopathological mechanisms of PTSD: emerging pharmacotherapies and clinical perspectives. ACS Chemical Neuroscience, 16(13), 2355–2370. https://doi.org/10.1021/acschemneuro.5c00335
McEwen, B. S. (1998). Stress, adaptation, and disease: allostasis and allostatic load. Annals of the New York Academy of Sciences, 840(1), 33–44. https://doi.org/10.1111/j.1749-6632.1998.tb09546.x
Powers, M. B., Hays, S. A., Rosenfield, D., Porter, A. L., Gallaway, H., Chauvette, G., … Rennaker, R. L. (2025). Vagus nerve stimulation therapy for treatment-resistant PTSD. Brain Stimulation, 18(3), 665–675. https://doi.org/10.1016/j.brs.2025.03.007
Robinson, R. G., & Jorge, R. E. (2016). Post-stroke depression: a review. American Journal of Psychiatry, 173(3), 221–231. https://doi.org/10.1176/appi.ajp.2015.15030363
Systematic review of PTSD prevalence after stroke (2024). ScienceDirect. Retrieved from https://www.sciencedirect.com/science/article/pii/S002239992400326X [30 studies, N = 4,320; weighted median prevalence 17.5%]
Comments